Industry Partners on doclift: How a Medical Affairs Platform Contributes to Education

Alongside hospitals and professional societies, doclift also lists companies from pharma and biotech as partners. That raises a fair question – and deserves an honest answer.

What industry partners contribute

The most visible contribution is expertise on narrowly defined topics. One example from the partner directory: the AbbVie Medical Institute, with expert courses on BoNT-A injection techniques and patient management – practical knowledge on a technique that has to be learned properly.

Other partners cover fields where independent continuing education is thin on the ground: rare diseases and complement biology, RNA interference, rare metabolic disorders, immunology in autoimmune disease. Areas where often only a handful of institutions have real experience at all.

Where the line is drawn

Education funded by companies that sell products in that exact field is a conflict of interest – no matter how good the content is. That can't be argued away, only structurally contained:

• Transparent labeling of the sender
• Separation of program and sponsoring – digital exhibitor spaces instead of slides inside the talk
• CME accreditation through the responsible professional society, not the sender

Why the pull model helps here

Whoever offers content instead of pushing it submits to a quality filter: what nobody opens voluntarily doesn't work either. Product messaging dressed up as education fails faster on a medical affairs platform built this way than on any advertising channel.

Conclusion

Excluding industry knowledge from continuing education would mean, in some niches, having no education at all. What matters isn't whether industry is involved – it's whether it stays clear who's speaking.